Satellos (formerly ICo Therapeutics)
Vancouver · Founded 2005
About Satellos (formerly ICo Therapeutics)
Satellos specializes in the research and development of drug delivery technologies.
Company Facts
- Founded: 2005
- Legal name: Satellos Bioscience Inc.
- Operating status: IPO
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $65.8M
- Funding stage: IPO
- Last round: Post-IPO Equity (Feb 2026)
- Website: satellos.com
- Phone: 604.602.9414
Social Profiles
Canonical: https://fsome.com/organization/satellos-formerly-ico-therapeutics-8405875 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.